1356483-72-1Relevant academic research and scientific papers
METALLOENZYME INHIBITOR COMPOUNDS
-
Page/Page column 49, (2020/07/25)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
METALLOENZYME INHIBITOR COMPOUNDS
-
Paragraph 0313; 0314; 0315; 0316, (2018/07/29)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
METALLOENZYME INHIBITOR COMPOUNDS
-
Paragraph 0523; 0524; 0525; 0526, (2018/07/29)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 51-52, (2012/02/05)
The invention involves compounds of structural Formula (I) and the pharmaceutically acceptable salts thereof. The compounds of the invention are effective at selectively inhibiting CYP11B2, and are therefore useful for the treatment or prophylaxis of disorders that are associated with elevated aldosterone levels, including, but not limited to, hypertension and heart failure.
